FDA 483 - Patheon Italia S.p.A

Patheon Italia S.p.A., a sterile drug product manufacturer in Ferentino, Italy, was cited for multiple deficiencies during an FDA inspection. Observations included inadequate deviation investigations, issues with equipment and process validation, and insufficient laboratory controls. These findings indicate a lack of robust quality systems to ensure the sterility and quality of drug products.